leisure time -WSS

leisure time

author：fashion 2025-08-12 08:27:13 - browse：7334

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Covid hospitalizations on the rise, Humana says

WSS

Orchard's therapy for neuron disease in children wins FDA approval

How generative AI is inspiring dreams of a health data revolution

How generative AI is inspiring dreams of a health data revolution

ALS advocates say criticism of new drugs misses bigger picture

Crinetics acromegaly drug succeeds in late

Gene editing the human germline: What are the risks?

entertainment

leisure time

knowledge

Alkermes shareholders re

Nurses recount patients attacks

Continuity nursing helped my family in our darkest PICU moments

Neuroscience’s long legacy of racism

23andMe had bad news about my health. I wish a person had delivered it

Methadone treatment changes are coming. Do they go far enough?

ChatGPT in medicine: STAT answers readers' burning questions

AstraZeneca chief proposes a novel edit to the drug pricing bill

State Dept. review finds Biden bears some blame for Afghanistan failures

App could help diagnose ear infections more accurately — and at home

hotspot

UnitedHealth increases loan offers after Change Healthcare outage

How to fix cancer clinical trials' diversity problem

Crinetics acromegaly drug succeeds in late

Plastic surgeons increase patient psychiatric screenings

How generative AI is inspiring dreams of a health data revolution

Nurses recount patients attacks

hotspot

Wikipedia

Wikipedia

knowledge